Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PRAD | rs139080352 | chr10:99421132 | CTT/C | 4.07E-9 | 472 | 31.37 | 29.17 | 23.75 | KM Plot |
| PRAD | rs139111288 | chr4:187811656 | C/A | 2.56E-6 | 478 | 31.13 | 27.88 | 26.8 | KM Plot |
| PRAD | rs139157130 | chr12:768243 | TTA/T | 4.54E-5 | 483 | 31.03 | 31.12 | 29.23 | KM Plot |
| PRAD | rs139232096 | chr3:133455172 | C/T | 5.67E-5 | 492 | 30.9 | 30.93 | 35.33 | KM Plot |
| PRAD | rs139247166 | chr4:187812670 | T/TATTA | 2.06E-6 | 483 | 31.13 | 28.57 | 26.8 | KM Plot |
| PRAD | rs139268548 | chr5:138253220 | TTTTA/T | 1.28E-6 | 480 | 32.45 | 30.8 | 25.2 | KM Plot |
| PRAD | rs139365463 | chr12:52818899 | TG/T | 0.000153 | 491 | 29.23 | 36.05 | 22.93 | KM Plot |
| PRAD | rs139392305 | chr9:72860625 | A/G | 1.73E-5 | 493 | 30.8 | 31.35 | 22.45 | KM Plot |
| PRAD | rs139872934 | chr2:107543830 | C/T | 1.08E-6 | 489 | 30.97 | 29.95 | 28.93 | KM Plot |
| PRAD | rs139917442 | chr11:51514678 | C/T | 8.87E-8 | 480 | 31.33 | 27.73 | 21.18 | KM Plot |
| PRAD | rs139931853 | chr4:187810660 | AGGCC/A | 1.9E-6 | 485 | 31.23 | 28.57 | 26.8 | KM Plot |
| PRAD | rs14000 | chr1:109822509 | C/T | 1.34E-12 | 494 | 16.93 | 29.25 | 31.27 | KM Plot |
| PRAD | rs140037437 | chr9:124286260 | C/CCCA | 0.00016 | 483 | 31.07 | 31.43 | 20.98 | KM Plot |
| PRAD | rs140087804 | chr17:62985007 | CAG/C | 1.23E-8 | 478 | 30.8 | 32.18 | 19.63 | KM Plot |
| PRAD | rs140160392 | chr16:58040502 | G/T | 2.04E-5 | 488 | 30.8 | 31.8 | 44.3 | KM Plot |